AIRS Medical Inks Partnership Agreement With FONAR Corporation, Leveraging the Experience of the Pioneering Company in MRI... Success Cases to Be Presented at RSNA 2023
AIRS Medical Inks Partnership Agreement With FONAR Corporation, Leveraging the Experience of the Pioneering Company in MRI... Success Cases to Be Presented at RSNA 2023
SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ -- AIRS Medical, the leading AI-powered healthcare solution provider, recently announced a strategic partnership with FONAR Corporation (NASDAQ:FONR), the pioneer company in the MRI industry, to accelerate and develop business in North America.
韓國首爾，2023年11月6日 /PRNewswire/ — 領先的人工智能醫療解決方案提供商AIRS Medical最近宣佈與核磁共振成像行業的先驅公司FONAR Corporation（納斯達克股票代碼：FONR）建立戰略合作伙伴關係，以加速和發展在北美的業務。
AIRS Medical's product SwiftMR enhances the quality of MRI images through fine-tuned deep learning technology. SwiftMR can reduce MRI scan times by up to 50% while enhancing image quality using AI-powered denoising and sharpening. FONAR, founded in 1978, introduced the first commercial MRI scanner in 1980. Today its signature product is the 0.6T UPRIGHT MRI. The FONAR UPRIGHT acquires MR images in an open magnet that accommodates a wide variety of static and dynamic patient postures, including sitting; standing; upright flexion, extension, lateral bending, and rotation; as well as recumbent.
AIRS Medical 的產品 SwiftMR 通過微調的深度學習技術提高了 MRI 圖像的質量。SwiftMR 可以將磁共振成像掃描時間縮短多達 50%，同時使用人工智能驅動的去噪和銳化來提高圖像質量。FONAR 成立於 1978 年，於 1980 年推出了第一臺商用磁共振成像掃描儀。如今，它的標誌性產品是 0.6T UPRIGHT 核磁共振。FONAR UPRIGHT 在開放式磁體中採集 MR 圖像，該磁體可容納各種靜態和動態的患者姿勢，包括坐姿、站立、直立屈曲、伸展、橫向彎曲和旋轉，以及臥着。
Through this partnership with FONAR, AIRS Medical has expanded the application of SwiftMR beyond 1.5T and 3.0T MRIs to include lower-field MRI scanners, securing access to an expanded market segment. Kevin Yang, Head of AIRS Medical's U.S. Operations & Clinical Research said, "AIRS Medical looks forward to the strategic partnership with FONAR. The combined efforts of both parties will accelerate our growth and strengthen our North American business capabilities. We expect that this agreement, leveraging FONAR's 45 years of expertise and capabilities, will bolster various aspects of our business operations in the U.S. market for SwiftMR, including sales, marketing, and even research collaborations."
通過與FONAR的合作，AIRS Medical已將SwiftMR的應用範圍擴展到1.5T和3.0T MRI以外，包括低場磁共振成像掃描儀，從而確保了進入更大細分市場的機會。AIRS Medical美國運營與臨床研究負責人楊凱文說：“AIRS Medical期待與FONAR建立戰略合作伙伴關係。雙方的共同努力將加速我們的增長並增強我們在北美的業務能力。我們預計，該協議利用FONAR45年的專業知識和能力，將加強我們在SwiftMR在美國市場業務運營的各個方面，包括銷售、市場營銷甚至研究合作。”
Under the slogan "Breaking the common belief of MRI through AI," AIRS Medical will showcase a range of cutting-edge AI healthcare technologies and advancements at RSNA 2023. A noteworthy development this year is clearance from the US FDA to expand the application of SwiftMR to all body parts, all pulse sequences, and all scanner models with 0.25T, 0.6T, 1.5T, and 3.0T.
在 “通過人工智能打破核磁共振成像的普遍信念” 的口號下，AIRS Medical將在2023年RSNA上展示一系列尖端的人工智能醫療技術和進步。今年一項值得注意的進展是美國食品藥品管理局批准將SwiftMR的應用擴展到所有身體部位、所有脈衝序列以及0.25T、0.6T、1.5T和3.0T的所有掃描儀型號。
In addition, AIRS Medical will showcase two accepted research abstracts and host two AI Theater Presentations. Yangsean Choi, MD, will discuss clinical applications and on-going research using SwiftMR in neuroradiology. John Greenhalgh, Ph.D., Vice President of Research and Development at FONAR Corporation, will share his experience successfully implementing SwiftMR in FONAR's UPRIGHT MRI systems. Both talks will be held at the RSNA AI Theater. Details can be found here. Please be sure to visit us at RSNA Booth #4552.
此外，AIRS Medical將展示兩份公認的研究摘要，並舉辦兩場人工智能劇院演講。Yangsean Choi 醫學博士將討論在神經放射學中使用 SwiftMR 的臨床應用和正在進行的研究。FONAR Corporation研發副總裁約翰·格林哈爾格博士將分享他在FONAR的UPRIGHT中成功實施SwiftMR的經驗 磁共振成像系統。兩場會談都將在RSNA AI劇院舉行。詳細信息可以在這裏找到。請務必在 RSNA 展位 #4552 參觀我們。
SOURCE AIRS Medical Inc.
來源 AIRS Medical Inc
譯文內容由第三人軟體翻譯。